
DiaMentis offers a non-invasive tool to help clinicians diagnose mental health disorders more quickly and objectively. The software uses electroretinography biosignatures and AI to analyze retinal data and generate diagnostic reports as a SaMD. It is a Software as a Medical Device (SaMD) designed for the mental health diagnostic market, scalable and deployable with partnerships. Spun off from Université Laval in Canada, the company targets the mental health market with a scalable, easy-to-deploy solution. The goal is to improve accuracy, reduce misdiagnosis, lower healthcare costs, and support personalized treatment decisions.

DiaMentis offers a non-invasive tool to help clinicians diagnose mental health disorders more quickly and objectively. The software uses electroretinography biosignatures and AI to analyze retinal data and generate diagnostic reports as a SaMD. It is a Software as a Medical Device (SaMD) designed for the mental health diagnostic market, scalable and deployable with partnerships. Spun off from Université Laval in Canada, the company targets the mental health market with a scalable, easy-to-deploy solution. The goal is to improve accuracy, reduce misdiagnosis, lower healthcare costs, and support personalized treatment decisions.